Autophagy is a catabolic process that ensures homeostatic cell clearance and is deregulated in a growing number of myopathological conditions. Although FoxO3 was shown to promote the expression of autophagy-related genes in skeletal muscle, the mechanisms triggering autophagy are unclear. We show that TSC1-deficient mice (TSCmKO), characterized by sustained activation of mTORC1, develop a late-onset myopathy related to impaired autophagy. In young TSCmKO mice, constitutive and starvation-induced autophagy is blocked at the induction steps via mTORC1-mediated inhibition of Ulk1, despite FoxO3 activation. Rapamycin is sufficient to restore autophagy in TSCmKO mice and improves the muscle phenotype of old mutant mice. Inversely, abrogation of mTORC1 signaling by depletion of raptor induces autophagy regardless of FoxO inhibition. Thus, mTORC1 is the dominant regulator of autophagy induction in skeletal muscle and ensures a tight coordination of metabolic pathways. These findings may open interesting avenues for therapeutic strategies directed toward autophagy-related muscle diseases.
INTRODUCTION
Muscle wasting, a hallmark of genetic and acquired muscle pathologies, is also associated with aging, cancer, AIDS, and chronic diseases of the heart, lung, or kidney. Muscle size depends on the balance between protein synthesis and protein degradation, the latter being ensured by the ubiquitin-proteasome pathway and the autophagy process (Rü egg and Glass, 2011) . Despite the identification of the main molecular pathways involved in the regulation of this homeostatic balance, our understanding of the integrated signaling network remains limited.
Muscle growth is a costly process restricted to optimal nutrient and energy availability. The mammalian target of rapamycin complex 1 (mTORC1), which includes mTOR and regulatory associated protein of mTOR (raptor), is a conserved regulator of cell growth that integrates cellular inputs to ensure translation, lipid synthesis, and organelle biogenesis (Laplante and Sabatini, 2012) . Most of these signals converge on the heterodimer TSC1/TSC2 (tuberous sclerosis complex 1 and 2) that functions as a GTPase-activating protein for the mTORC1 activator, the Ras-related binding protein Rheb (Inoki et al., 2003; Tee et al., 2003) . Sensing of amino acids is, by contrast, independent of TSC1/TSC2 but mediated by the RagulatorRag complex that recruits mTORC1 to lysosomal membranes and promotes its activation by Rheb (Sancak et al., 2010) .
Macroautophagy, hereafter referred to as autophagy, is involved in the constitutive turnover of organelles and macromolecules, as well as in the adaptive degradation of cellular components in response to different stresses such as low nutrient or energy supply. Upon autophagy induction, double-membrane vesicles, called autophagosomes, engulf large parts of the cytoplasm and release degraded components following fusion with lysosomes, thus ensuring metabolite recycling (Lum et al., 2005) . In most cell types, autophagy induction relies on the release of the inhibition of the Ulk1-Atg13-FIP200 complex by mTORC1 (Kim et al., 2011) . By contrast, in skeletal muscle, autophagy was suggested to be independent of mTORC1 but controlled by the forkhead box O3 protein (FoxO3), which promotes the transcriptional induction of atrogenes (notably encoding the E3 ubiquitin ligases atrogin1/MAFbx and MuRF1) and autophagy-related genes (Mammucari et al., 2007; Zhao et al., 2007) .
In contrast to this apparent clear-cut separation between mTORC1-dependent anabolism and FoxO-dependent catabolism, integration of the entire regulatory network responsible for muscle homeostasis appears to be more complicated. In particular, the common control of mTORC1 and FoxO pathways by the upstream Akt protein and the existing feedback loops make it difficult to predict the physiological consequences of their modulation. We previously showed that inactivation of mTORC1 in skeletal muscle by deleting raptor (RAmKO mice) leads to muscle atrophy (Bentzinger et al., 2008) . Inversely, activation of Akt promotes muscle growth. Although this effect can be blocked by rapamycin, the contribution of the inhibition of FoxO-dependent catabolism to this hypertrophy response is not clear (Bodine et al., 2001; Lai et al., 2004) . Importantly, deletion of Tsc1 in skeletal muscle (TSCmKO mice), which leads to simultaneous activation of mTORC1 and FoxO pathways, causes atrophy of most muscles (Bentzinger et al., 2013) .
Here, we investigated the relative importance of mTORC1 and FoxO signaling for muscle homeostasis and their role in the regulation of autophagy. We show that sustained activation of mTORC1 in TSCmKO mice leads to a severe, late-onset phenotype reminiscent of myopathies caused by impaired autophagy. Despite simultaneous activation of FoxO3 signaling in TSCmKO mice, induction of constitutive and starvation-dependent autophagy is inhibited in mutant animals. This autophagy blockade and the myopathy of old TSCmKO mice are largely reversible by rapamycin. We also establish that mTORC1 inactivation, in RAmKO mice, is sufficient to induce autophagy. Our data thus demonstrate that mTORC1 is the dominant regulator of autophagy in skeletal muscle.
RESULTS
TSCmKO Mice Develop a Severe, Late-Onset Myopathy TSCmKO mice, obtained by deleting Tsc1 specifically in muscle tissues and characterized by constant activation of the mTORC1 pathway, are macroscopically indistinguishable from control animals at an early age (Bentzinger et al., 2013) . However, after 9 months of age, mutant mice developed a severe kyphosis (Figure 1A) and eventually died around one year of age (data not shown). They were significantly lighter than control mice, which was largely related to a loss in fat and lean body mass (Table 1) . Like in young mutant mice (Bentzinger et al., 2013) , tibialis anterior (TA), extensor digitorum longus (EDL), quadriceps, and gastrocnemius muscles from 12-month-old TSCmKO mice were lighter than in control mice, while soleus was significantly heavier (Table 1) . The mTORC1 pathway remained activated in 12-month-old TSCmKO mice as indicated by the increased phosphorylation of the mTORC1 target ribosomal protein S6 ( Figure S1A ). Moreover, phosphorylation of Akt was dampened ( Figure S1A ), consistent with the negative feedback loop exerted by mTORC1 signaling onto IRS1 (Harrington et al., 2004; Bentzinger et al., 2008) .
The loss of fat and lean body mass in old TSCmKO mice was due to the genetic depletion of TSC1 in muscle, as TSC1 expression and/or the levels of phospho-S6 were not modified in other tissues such as liver, fat, or kidney ( Figure S1A ). Although levels of blood glucose were slightly lower in old TSCmKO mice than in age-matched controls, insulin levels and the two cachexia markers TNFa and IL6 (Spä te and Schulze, 2004; Tisdale, 2010) were not significantly changed ( Figure S1B ).
Histological examination of muscles from 12-month-old TSCmKO mice revealed vacuolated fibers, basophilic fibers, and intracellular inclusions ( Figures 1B and S1C ). Most inclusions were positive for acid phosphatase, nicotinamide adenine dinucleotide (NADH), and COX, but were devoid of adenosine triphosphatase (ATPase) activity, indicating the presence of mitochondria, sarcoplasmic reticulum, and lysosomes and the loss of myofibrillar elements in these regions ( Figure S1D ). As reported in human vacuolar myopathies (De Bleecker et al., 1993) , some, but not all, vacuoles were positive for sarcolemmal components such as dystrophin or b-dystroglycan ( Figure S1E ). Abnormally large myonuclei were often observed in hematoxylin and eosin (H&E)-stained muscle sections ( Figure 1B) or by immunohistological staining with anti-lamin C antibody ( Figure 1C ). These pathological changes in skeletal muscle were absent in 3-month-old mice but became visible in 6-month-old TSCmKO mice ( Figure S1F ).
Ultrastructural analysis by electron microscopy confirmed the presence of enlarged myonuclei and vacuoles in EDL and soleus muscles from 9-month-old TSCmKO mice ( Figure 1D ). Contractile compartments of some muscle fibers were shrunken with an enlarged peripheral region containing giant and vacuolated mitochondria or accumulation of aberrant membrane structures (Figures 1D and S1G) . Sarcomeres were sometimes disorganized with accumulation of mitochondria ( Figure S1G ).
Immunostaining against type I and II myosin heavy chain (MHC) on TA sections from 12-month-old TSCmKO mice revealed a marked atrophy of type IIb fibers, whereas type IIa/IIx fibers were significantly hypertrophic ( Figure 1E ). The number of fibers and the fiber-type proportions were unchanged compared to control (data not shown). In soleus, type I fibers were significantly smaller than in control mice, whereas type IIa/IIx fibers varied from atrophic to hypertrophic fibers (Figure 1F) . Such atrophic fibers likely resulted from fiber splitting, consistent with an increased number of fibers in soleus from 12-month-old mutant mice compared to controls (data not shown).
To determine whether the pathological changes correlated with impaired muscle function, we measured the in vitro force of the atrophic EDL and the hypertrophic soleus from 12-month-old mice. As shown in Table 1 , specific twitch (sPt) and tetanic (sPo) forces were reduced to less than 50% in both mutant muscles compared to controls. Thus, constant activation of mTORC1 results in muscle weakness that is decoupled from muscle size. A similar decline in sPt and sPo was found in soleus from 3-month-old TSCmKO mice, indicating that the loss of muscle force precedes the detection of the myopathic alterations (Table 1) .
Together, these observations indicate that sustained activation of mTORC1 in skeletal muscle results in a multifaceted myopathy characterized by the presence of vacuoles and the accumulation of abnormal organelles.
Muscle Alterations in TSCmKO Mice Are Related to Impaired Autophagy The similarity of the phenotype to mice with impaired autophagy (Masiero et al., 2009 ) prompted us to evaluate autophagy markers in TSCmKO mice at different ages. Because Akt was inhibited in TSCmKO mice, one could expect activation of FoxO3 signaling, another regulator of autophagy (Mammucari et al., 2007; Zhao et al., 2007) . Nonetheless, we did not detect a major decrease in the phosphorylation of FoxO1/FoxO3 proteins in muscles from 6-or 12-month-old mutant mice (Figure 2A) , and expression of MuRF1 and Atrogin1, which were significantly induced in TA from 3-month-old mice, was not changed in older mutant mice ( Figure 2B and data not shown). 
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The SQSTM1/p62 protein is an autophagy-specific substrate, the accumulation of which is used as a readout for autophagy impairment (Klionsky et al., 2012) . In 12-month-old TSCmKO mice, p62 accumulated in the cytoplasm or as focal aggregates in most muscle fibers ( Figure 2C ) irrespective of their fiber type (data not shown). Basophilic cells and intracellular inclusions located in the periphery of the cells were positive for p62, whereas vacuoles and central inclusions were mostly negative ( Figure S2A ). p62 levels were increased in both the detergentsoluble and -insoluble fractions from TA and soleus muscles, confirming the presence of aggregates in muscle fibers (Figure 2D and data not shown). Concomitantly, levels of ubiquitinylated proteins were increased in muscles from 12-month-old TSCmKO mice and p62 aggregates were generally positive for ubiquitin (Figures S2B and S2C) . p62 also accumulated in muscle from younger TSCmKO mice ( Figure 2D ), but aggregates were not detected in 3-month-old mice and were less frequent in 6-month-old mice than in 12-month-old animals ( Figure 2C ). This indicates that p62 accumulates prior to morphological muscle alterations.
Because accumulation of p62 is a hallmark of impaired autophagy flux, we next evaluated levels of the soluble (LC3I) and autophagosome-associated (LC3II) forms of the widely used LC3 (microtubule-associated protein light chain 3) autophagy marker. The conversion of LC3I to LC3II is representative of the accumulation of autophagosomes in cells (Klionsky et al., 2012) . In TA from 3-and 6-month-old TSCmKO mice, levels of LC3I were increased compared to control, while both LC3I and LC3II forms tended to accumulate in 12-month-old TSCmKO mice. By contrast, LC3I and LC3II were not altered in soleus muscles ( Figure 2D ). It is noteworthy that lysosome-related vesicles, marked with the lysosomal-associated membrane protein 1 or 2 (Lamp1/Lamp2), also accumulated in muscle fibers from 12-month-old TSCmKO mice, especially at the periphery of the cells and around myonuclei ( Figures 2E and S2D ). These lysosomal structures rarely colocalized with p62 aggregates (Figure S2E) . Expression of Cathepsin L, a lysosomal enzyme involved in the degradation of autophagic content, was increased in TA and even more so in soleus from TSCmKO mice at all ages ( Figure 2D ). Transcript levels of Cathepsin L and p62 were increased in TA and soleus muscles from 3-month-old TSCmKO mice, consistent with FoxO activation, but their expression normalized in older mice, as observed for MuRF1. LC3 messenger RNA (mRNA) levels were not changed at any age (Figures 2F and 2G) . Together with the morphological alterations described above, these observations indicate that autophagy is perturbed in TSCmKO mice.
Induction of Constitutive and Starvation-Dependent Autophagy Is Blocked in Skeletal Muscle from TSCmKO Mice
To better understand the autophagy-related defects detected in TSCmKO mice, we explored the ability of 2-month-old mutant mice to increase autophagy flux in muscle when submitted to a physiological stimulus like fasting (Mizushima et al., 2004) . To distinguish between constitutive and starvation-induced autophagy, mice were examined in fed or basal conditions and following food deprivation (starved). Fed mice were sacrificed in the late evening when they were actively eating, while basal conditions refer to the early morning during the light-on circadian period. Fed mice showed activation of Akt and S6 similar to mice that were fasted overnight and then refed for 4 hr in the morning (data not shown). In control muscle, autophagy was induced in basal conditions, as shown by the conversion of LC3I to LC3II, compared to fed conditions ( Figure S3A ). This induction of autophagy correlated with Akt/mTORC1 inhibition ( Figure S3A ), whereas transcription of the main autophagyrelated genes remained unchanged ( Figure S3B ). After 24 or 48 hr of starvation, autophagy was greatly induced, as reflected by a major increase in the LC3II/LC3I ratio ( Figure S3A ), and was paralleled by upregulation of autophagy-related genes (Figure S3B) . Levels of phospho-Akt and phospho-S6 were not significantly reduced compared to basal conditions ( Figure S3A ).
In stark contrast to controls, TSCmKO mice showed constant high phosphorylation of S6 and low levels of phospho-Akt regardless of their nutritional status ( Figure 3A) . Interestingly, the energy-sensing 5 0 AMP-activated protein kinase (AMPK) was similarly activated upon starvation in control and mutant mice ( Figure S3C ). Starvation increased the percentage of myonuclei positive for FoxO3, indicative of its active state (Figure S3D) ; mRNA expression of MuRF1 and Atrogin1 ( Figure 3B ) was also increased in TA muscle of control and TSCmKO mice. It should be noted, however, that the percentage of FoxO3-positive myonuclei was higher in TSCmKO mice than in controls in both basal and starved conditions ( Figure S3D ). These results are consistent with the strong inhibition of Akt and the normal activation of AMPK in TSCmKO mice. Together, these data support the idea that starvation-induced activation of FoxO3 not only depends on Akt inhibition, but further requires AMPK activation, consistent with recent in vitro results obtained in muscle cells (Sanchez et al., 2012) . When TSCmKO mice were starved for 12, 24, or even 48 hr, loss of body weight was comparable to that in control mice (data not shown). Starvation did not lead to major muscle alterations in mutant mice, although a few fibers from soleus muscle of TSCmKO mice contained small vacuoles and abnormally large myonuclei that were not observed in control mice or fed mutant mice ( Figure S3E ). Starvation increased the levels of p62 protein in mutant muscle ( Figure 3A ), but the protein did not form large aggregates like in 12-month-old mice (Figure S3F) . Interestingly, in TA muscle from TSCmKO mice, levels Table S1 . M, month. (E) Lysosomal vesicles stained with anti-Lamp2 antibody accumulate in muscle fibers, especially in the periphery of muscle fibers (arrow) and around myonuclei (open arrow) in 12-month-old (M, month) TSCmKO mice, but not in control (Ctrl) animals. Scale bar = 50 mm. (F and G) Expression of some autophagy-related genes is significantly increased in TA (F) and soleus (G) from 3-month-old TSCmKO mice compared to control mice. This difference becomes less prominent in 6-and 12-month-old mice. Values are mean ± SEM of data normalized to b-actin levels; *p < 0.05. M, month.
Figure 3. Autophagy Induction Is Blocked in TSCmKO Muscles
(A) Two-month-old TSCmKO (TSC) and control (Ctrl) mice were examined in fed, basal, and starved (St24 or St48 hr) conditions. Immunoblots using antibodies to detect Akt and S6 protein, specific phosphorylation sites (P) in the respective proteins, and autophagy-related proteins show that mutant TA muscle was resistant to starvation-mediated autophagy induction. Data are normalized to a-actinin and representative of three independent experiments; for quantification, see Table S2 . (B) Transcript expression of MuRF1 and Atrogin1 is efficiently upregulated in TA from TSCmKO mice after 24 or 48 hr of starvation (St). Expression levels are normalized to b-actin. Values are mean ± SEM; $ p < 0.05, $$ p < 0.005 compared to same genotype in basal conditions.
(C and D) TSCmKO mice expressing GFP-LC3 display a reduced number of GFP-positive puncta in TA muscle compared to control (Ctrl) after 24 hr of starvation (St24) (C). This effect is confirmed by quantifying the number of GFP-LC3 puncta in a volume unit (Vol) of 3.6 3 10 5 mm 3 (D). Data are mean ± SEM; ***p < 0.0005.
Scale bar = 50 mm.
(E) Treatment with chloroquine (+) leads to only a mild increase in LC3II levels in TA muscle from starved TSCmKO (TSC) mice, indicating that LC3I accumulation in these mice is due to impaired induction steps. 
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mTORC1 Inhibits Autophagy Induction in Muscle of LC3I and LC3II remained unchanged between fed, basal, and starved conditions (even after prolonged fasting for 48 hr), and they were comparable to those observed in fed control mice ( Figure 3A ). To confirm this result, we crossed TSCmKO mice with GFP-LC3 transgenic mice (Mizushima et al., 2004) and examined the number of green fluorescent protein (GFP)-positive puncta, representative of autophagosomes, in control and mutant muscle. In basal conditions, the number of GFP-LC3 puncta in TA was similar in TSCmKO and control mice. However, the number of GFP-LC3 puncta did not increase in TSCmKO muscles after 24 hr of starvation, while, as expected, the number of puncta more than doubled in control mice ( Figures 3C and 3D) . These results are consistent with either a blockade in autophagy induction or an excessive exhaustion of the vesicles. To discriminate between the two possibilities, starved mice were treated with chloroquine, a lysosomal inhibitor that prevents the degradation of the autophagic content. While chloroquine treatment strongly increased LC3II levels in control mice, LC3II was only slightly increased in TSCmKO mice, indicating that the reduced number of autophagosomes in mutant muscles is due to impaired autophagy induction ( Figure 3E ). We next addressed whether this defect in autophagy induction was caused by abnormal expression of autophagy-related genes (Mammucari et al., 2007) . Consistent with FoxO being active, mRNA expression of Cathepsin L, p62, Gabarapl1, and Bnip3 was efficiently increased after 24 or 48 hr of starvation in TSCmKO mice compared to control mice ( Figures 3F and  S3G ). Cathepsin L and the two positive regulators of autophagy, Bnip3 and Beclin 1, also showed normal or higher protein expression in mutant mice ( Figure S3C ). Similar results were obtained in soleus muscle (Figures S3H and S3I) . These results show that sustained activation of mTORC1 blocks the induction of constitutive and starvation-induced autophagy despite FoxO3 activation.
In cultured cells, mTORC1 has been shown to phosphorylate Ulk1 and thereby inhibit its activation by AMPK (Kim et al., 2011) . We therefore assessed the phosphorylation state of Ulk1 in TSCmKO muscles and found that the amount of the inactive, phosphorylated form of Ulk1 at S757 was markedly increased in all conditions compared to control, while there was no major change in the AMPK-dependent phosphorylation at S317 of Ulk1 in mutant mice ( Figure 3A) . To test whether this hyperphosphorylation of Ulk1 was responsible for the effect on autophagy, TA muscles from control and TSCmKO mice were coelectroporated with a tandem-dimer (td) red fluorescent protein (RFP) expression construct and a plasmid encoding the Ulk1 mutant S757A, which is insensitive to mTORC1 (Kim et al., 2011) . After 8 days and starvation of the mice for the final 36 hr, the number of GFP-LC3 puncta was significantly higher in RFP-positive fibers compared to RFP-negative fibers in TSCmKO muscle and became similar to that detected in control muscle ( Figures 3G and 3H) . Similar results were obtained when the wild-type form of Ulk1 was electroporated into TA muscle ( Figure S3J ). In contrast, no effect was observed using the empty plasmid, and electroporation of empty vector or Ulk1 encoding plasmid into control muscle did not affect the number of GFP-LC3 puncta ( Figure 3G and 3H) . These results indicate that mTORC1 mediates its inhibitory function on autophagy via Ulk1 and that restoration of Ulk1 is sufficient to normalize autophagy in TSCmKO muscle.
Hyperactivation of mTORC1 Is Sufficient to Block Autophagy Both In Vivo and In Vitro
To test whether acute depletion of the TSC complex could also block autophagy, we electroporated control muscles with small hairpin RNA (shRNA) constructs directed against Tsc1 and Tsc2 together with tdRFP expression plasmids. After 8 days, muscles were examined following starvation of the mice for the last 36 hr. Compared to muscle electroporated with control shRNA to Cd4, knockdown of Tsc1/Tsc2 in soleus muscle resulted in lower levels of TSC1 and TSC2 and higher levels of phospho-S6 (Figure 4A) . Indicative of reduced autophagy induction, the LC3II/ LC3I ratio was reduced ( Figure 4A ) and the number of GFP-LC3 puncta was significantly decreased in RFP-positive fibers of TA muscle electroporated with Tsc1/Tsc2 shRNA compared to RFP-negative fibers in the same muscle (Figures 4B and 4C) . No effect was detected with control shRNA directed against Cd4. In a similar experiment, when examining soleus muscle 4 weeks after electroporation of shRNA directed against Tsc2 together with an expression construct for nuclear GFP (nuGFP), TSC2 levels were reduced and high levels of phospho-S6 were detected ( Figure 4D) . Notably, the amount of p62 was increased in the examined muscles, and p62 accumulation was further observed by immunostaining in nuGFP-positive fibers expressing Tsc2 shRNA ( Figure 4E ). These results demonstrate that autophagy is also impaired following acute perturbation of mTORC1 signaling in adult mice.
In an additional step, we investigated whether sustained activation of mTORC1 would impair autophagy in vitro by isolating single fibers from EDL muscle of TSCmKO mice expressing GFP-LC3. Compared to fibers placed in growth medium, a strong increase in the number of GFP-positive puncta was observed when control fibers were incubated with medium depleted of amino acids and glucose. In contrast, the number of GFP-LC3 puncta remained low in TSCmKO fibers even after amino acid and glucose depletion ( Figures 4F, 4G, and S4A ). In addition, control fibers contained large, Lamp2-positive vesicles after starvation, whereas only few such structures could be detected in TSCmKO fibers ( Figure 4F ). Levels of p62 were slightly increased in mutant fibers compared to control, and as observed in vivo, TSCmKO fibers maintained high levels of phospho-S6 and low levels of phospho-Akt irrespective of the culture conditions ( Figures 4H and S4B ). These results demonstrate that the release of TSC1/TSC2 inhibition onto mTORC1 is sufficient to fully activate the pathway both in vivo and in vitro, hence contrasting with in vitro evidence suggesting that amino acid supply is absolutely required for mTORC1 activation, irrespective of other positive stimuli (Smith et al., 2005) .
Inactivation of mTORC1 Promotes LC3 Lipidation in Spite of FoxO Inhibition
Having established that sustained activation of mTORC1 impairs autophagy, we asked whether its inactivation would promote the autophagy flux by examining the response of 2-month-old RAmKO mice to food deprivation. Mutant mice displayed reduced phospho-S6 levels in fed, basal, and starved conditions compared to controls, in accordance with mTORC1 inactivation 
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(A-C) Coelectroporation of tdRFP and shRNA constructs directed against Tsc1 and Tsc2 results in hyperactivation of mTORC1 signaling after 8 days (A) and in a decreased number of GFP-LC3 puncta in transfected RFP-positive fibers (*) when mice were previously starved for 36 hr (B). GFP-LC3 puncta were quantified in a volume unit (Vol) of 3.6 3 10 3 mm 3 (C). Scale bar = 10 mm. Values are mean ± SEM. *p < 0.05.
(D and E) Four weeks after electroporating Tsc2 shRNA together with nuGFP in TA muscle, levels of phospho-S6 and p62 are increased compared to muscle electroporated with control Cd4 shRNA (D). Accumulation of p62 is detected by immunostaining in nuGFP-positive fibers in muscle electroporated with Tsc2 shRNA (E). Scale bar = 50 mm.
(F and G) Single muscle fibers isolated from GFP-LC3 expressing control mice (Ctrl) show induction of GFP-positive puncta and large Lamp2 vesicles (arrow) after 4 hr in glucose-and amino acid-deprived medium (St4) compared to fibers placed in growth medium (GM). These vesicles remain rare in fibers isolated from TSCmKO mice (F). Quantification of the number of GFP-LC3 puncta/mm 3 (G). Scale bar = 25 mm. Values are mean ± SEM.
(H) Immunoblots using antibodies that detect Akt and S6 protein and their phosphorylated forms reveal hyperactivation of mTORC1 signaling in TSCmKO fibers (TSC) in growth medium (GM) and after 4 hr without glucose and amino acid (St4).
( Figure 5A ). Conversely, phosphorylation of Akt ( Figure 5A ) and FoxO1/FoxO3 ( Figure S5A ) was maintained at high levels in starved mutant mice, and transcript levels of MuRF1 and Atrogin1 were markedly lower than in starved control mice ( Figure 5B) . After 12 or 24 hr of starvation, a similar loss of body mass was measured in RAmKO and control mice, and H&E staining revealed no obvious muscle alterations compared to basal conditions (data not shown). p62 protein accumulated in only a few muscle fibers from starved mutant mice, although the number and the size of these aggregates were increased compared to basal conditions ( Figure 5C ). Western blot analysis revealed similar low levels of p62 in TA from mutant and control mice (Figure 5D) . Interestingly, elevated levels of LC3II, similar to those in starved control mice, were detected in RAmKO muscle, regardless of the nutritive status of the mice ( Figure 5D ). To further evaluate the number of autophagosomes in muscle fibers, RAmKO mice were crossed with GFP-LC3 transgenic mice (Mizushima et al., 2004) . In basal conditions, the number of GFP-positive puncta in TA sections from RAmKO mice was significantly higher compared to control mice and similar to the number in TA from starved control mice ( Figures 5E and 5F ). After 24 hr of starvation, the number of GFP-LC3 puncta was not further increased in RAmKO mice, and we noticed that GFP-LC3 puncta were not distributed homogeneously in mutant muscle compared to control ( Figure 5F ). While in basal and starved conditions, chloroquine treatment enhanced LC3II levels in both mutant and control mice; in fed conditions, the amount of LC3II was only increased in RAmKO mice, supporting the idea that autophagy is permanently induced in mutant mice ( Figure 5D ). Contrasting with this result, transcript levels of autophagy-related genes were strongly reduced in muscles from starved mutant mice, consistent with increased Akt-dependent inhibition of FoxO compared to control mice ( Figures 5G and S5B) . Nevertheless, expression of most autophagy-related genes was significantly increased after starvation in mutant muscles, which could be related to starvation-induced activation of AMPK ( Figure S5A ). Cathepsin L, Cathepsin D, and Bnip3 protein levels were also reduced in mutant mice compared to control animals, while no major change was detected in the amount of Beclin 1 and phospho-Ulk1 S757 ( Figures 5D and S5A ). In contrast, phosphorylation of Ulk1 at S317 was strongly increased in RAmKO mice, suggesting that mTORC1 inactivation facilitates AMPK-dependent activation of Ulk1 in muscle ( Figure S5A ). Similar results were obtained in soleus muscle (Figures S5C and S5D) . Together, these data indicate that autophagy is induced in RAmKO muscles despite reduced FoxO-dependent transcription of autophagy genes.
To go further, autophagy markers were assessed in 6-monthold RAmKO mice: like in 2-month-old mice, mRNA levels of Cathepsin L, LC3, and Bnip3 were significantly decreased in mutant mice, and the amount of LC3II was increased ( Figures  S5E-S5G ). In parallel, protein expression of Cathepsin L was strongly reduced while the levels of Cathepsin D and Lamp1 were only slightly lowered in mutant TA muscle compared to control ( Figure S5G ). No major difference was observed in the acid phosphatase activity of RAmKO and control muscles, except in regenerative fibers, which were strongly reactive to the staining ( Figure S5H ). While p62 levels were unchanged in detergent-soluble and -insoluble protein fractions from mutant muscle, p62 aggregates were observed in many myofibers (Figures S5G and S5I) . Similarly, Lamp1/Lamp2-positive structures accumulated in a few fibers but did not colocalize with p62 aggregates (Figures S5J and S5K) . Lastly, the amount of ubiquitinylated proteins was increased in TA muscle from starved 2-month-old (100 ± 4% in control; 122 ± 7% in mutant) and 6-month-old (100 ± 2% in control; 191 ± 17%** in mutant, **p < 0.005) RAmKO mice ( Figures S5L and S5M) . Together, these results suggest that lysosomal activity may be slowed down in RAmKO muscles, thereby limiting the final degradation steps of autophagy and resulting in the accumulation of autophagic substrates.
Lastly, as mTOR complex 2 (mTORC2), characterized by the rapamycin-insensitive companion of mTOR (rictor), was also reported to indirectly regulate autophagy via Akt in muscle cells (Mammucari et al., 2007) , we examined whether mice specifically depleted for rictor in skeletal muscle (RImKO; Bentzinger et al., 2008) would show changes in autophagy. No difference in the number of GFP-LC3 puncta was observed in muscles of RImKO mice compared to control mice in basal and starved conditions ( Figures S5N and S5O) . Furthermore, LC3I, LC3II, and p62 levels in 3-and 6-month-old RImKO mice were similar to control animals ( Figures S5P and S5Q) . These results indicate that autophagy in skeletal muscle is not regulated by mTORC2.
Rapamycin Restores the Autophagy Flux and Reverses Muscle Alterations in TSCmKO Mice
Having shown that mTORC1 inhibition is required and sufficient to trigger autophagy induction, we assessed whether inhibition of mTORC1 would restore autophagy and reverse the myopathic phenotype of TSCmKO mice. In TA muscle, rapamycin normalized phospho-Akt and phospho-S6 levels in starved 2-monthold and 12-month-old mutant mice, indicating that mTORC1 was efficiently inhibited by the treatment ( Figure 6A ). Rapamycin treatment decreased the amount of p62 in both 2-and 12-month-old TSCmKO mice and restored the conversion of LC3I to LC3II and the number of GFP-LC3 puncta in starved TSCmKO mice ( Figures 6A-6C) . Levels of phospho-Ulk1 S757 and Beclin 1 were normalized by rapamycin ( Figures 6A and S6A) , while mRNA expression of the autophagy-related genes in starved mice was not significantly affected ( Figures 6D and S6B) . Similar results were obtained in soleus muscles (Figures S6C and S6D) . These results show that mTORC1 inhibition by rapamycin in TSCmKO mice is sufficient to restore autophagy induction. Morphological analyses of TA and soleus muscles revealed an improvement of the myopathy in 12-month-old TSCmKO mice when treated with rapamycin ( Figure 6E ). In particular, fibers with vacuoles or hematoxylin-positive inclusions were less frequent, and the accumulation of p62 aggregates was strongly reduced in rapamycin-treated mice ( Figure 6E ). Moreover, rapamycin reversed, at least partially, the atrophy of type IIb fibers in TA ( Figure 6F ) and the hypertrophy of type IIa/IIx fibers in soleus ( Figure S6E ). Most importantly, rapamycin normalized mass, specific twitch force (sPt), and specific tetanic force (sPo) of the TSCmKO soleus muscle (Figures 6G and 6H) . Altogether, these data indicate that rapamycin is sufficient to ameliorate the myopathy observed in old TSCmKO mice, which is likely due to the normalization of the autophagy flux. (legend continued on next page)
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DISCUSSION
Autophagy impairment has been positioned as a central pathomechanism related to neurodegenerative diseases, cancer, and aging-associated dysfunctions. By generating mice depleted for TSC1 in skeletal muscle (TSCmKO), we show that sustained activation of the mTORC1 pathway leads to a late-onset myopathy with muscle atrophy and severe muscle weakness. Previous reports established that excessive, as well as insufficient, autophagy flux damage muscle tissue (Mammucari et al., 2007; Masiero et al., 2009 ). Accordingly, TSCmKO muscles progressively accumulate p62 aggregates, vacuoles, and damaged organelles with age, supporting the idea that muscle atrophy in TSCmKO mice is at least partly caused by impaired autophagy flux. Soleus muscle was the only muscle analyzed with increased muscle weight, but this gain of mass was nonfunctional, as its force-drop was even higher than in EDL muscle. Although slow muscles were reported to have lower autophagy flux compared to fast muscles (Ogata et al., 2010) , soleus muscle was not spared from the accumulation of autophagic substrates in TSCmKO mice. Hence, whether the distinct muscle growth response to mTORC1 activation relies on differential autophagy impairment remains unclear, but one can hypothesize that it may be more complex than a simple fast versus slow muscle distinction and may also combine specific modulation of anabolism and proteasomal activity.
Contrasting the current view that autophagy is independent of mTORC1 in skeletal muscle and strictly depends on FoxO3 (Mammucari et al., 2007; Zhao et al., 2007) , we find here that sustained activation of mTORC1 blocks the induction of autophagy, despite increased FoxO3 activity, both in vivo and in vitro. As described in other cell types, this inhibitory effect of mTORC1 on autophagy in skeletal muscle was related to phosphorylation of Ulk1 protein at S757, which prevents its activation by AMPK in response to energy deprivation (Kim et al., 2011) . Inhibition of mTORC1 with rapamycin or overexpression of the Ulk1 mutant S757A in TSCmKO mice was sufficient to restore autophagy in vivo. Inversely, the sustained induction of autophagy in RAmKO mice, in spite of the strong activation of Akt, indicates that LC3 lipidation is also dictated by mTORC1 inactivation and does not require FoxO3 activation. This autophagy induction correlated with higher AMPKdependent phosphorylation of Ulk1 at S317, which is likely facilitated by mTORC1 abrogation as established in mouse embryonic fibroblast (MEF) cells (Kim et al., 2011) . These seemingly different results to previous studies conducted in muscle likely stem from experimental procedures, which may not reproduce the blocking effect of mTORC1 (Mammucari et al., 2007; Zhao et al., 2007 ). However, the described inability of rapamycin to increase the number of autophagosomes in mice that express a constitutively active form of Akt is more surprising (Mammucari et al., 2007) . This may be due to the complete inhibition of the FoxO pathway, thereby constituting a limiting factor for autophagy induction. In RAmKO mice, expression of Bnip3 and Beclin 1 proteins, which are essential for FoxO3-dependent activation of autophagy (Mammucari et al., 2007; Grumati et al., 2010) , was still detected, suggesting that FoxO3 activity is not completely blocked. Nonetheless, RAmKO mice did not respond to starvation by further inducing autophagy, which may be due to the limited upregulation of autophagy-related genes. Similarly, heterogeneous distribution of autophagosomes in muscle fibers from starved RAmKO mice and accumulation of p62 aggregates with age may reflect insufficient autophagy flux. Notably, we cannot rule out that the degradation steps of autophagy are limited in RAmKO mice due to restricted lysosomal activity, which may be related to FoxO inhibition in these mice. Hence, our findings strongly support the idea that constitutive autophagy, related to circadian feeding and activity, depends on the inhibition of the Akt/mTORC1 axis, a condition required for further stressinduced autophagy associated with the AMPK/FoxO3 axis (Sanchez et al., 2012) . In this system, mTORC1 constitutes the major upstream-limiting safety catch for autophagy that coordinates changes in catabolism and anabolism in a transcription-independent manner.
Growing evidence incriminates the decline of autophagy capacity in the age-related dysfunction of several tissues (Salminen and Kaarniranta, 2009) . Accordingly, the muscle phenotype described in TSCmKO mice is reminiscent of age-related loss of muscle mass and function, identified as sarcopenia. The concomitant loss of fat and changes in plasma glucose levels are also observed in mice with a muscle-specific deletion of Atg7 in which autophagy in skeletal muscle is blocked (Kim et al., 2013) , suggesting that similar mechanisms may account for the metabolic perturbation in TSCmKO mice. Notwithstanding, it is now well established that restoring autophagy flux, for instance by caloric restriction or by inhibiting the mTORC1 pathway, is sufficient to reverse some age-related alterations and to increase lifespan in different organisms (Mizushima et al., 2008; Harrison et al., 2009; Wohlgemuth et al., 2010) . Consistently, rapamycin improves the morphological and functional muscle phenotype of old TSCmKO mice. This effect was not driven by indirect activation of FoxO3 through (C) Accumulation of p62 (arrow) is observed rarely in muscle fibers in 2-month-old RAmKO mice in basal conditions and is slightly increased after 24 hr of starvation. Scale bar = 50 mm. (D) Two-month-old RAmKO (RA) and control (Ctrl) mice were submitted to fed, basal, or starved conditions (St24) with (+) or without (À) chloroquine treatment. Notably, immunoblots of TA mutant muscle reveal stronger LC3I-to-LC3II conversion, which is further increased with chloroquine. Data are normalized to a-actinin and represent three independent experiments; quantification is given in Table S4 . (E and F) Quantification of the number of GFP puncta in TA muscle of GFP-LC3-expressing RAmKO and control (Ctrl) under basal conditions and after 24 hr starvation (E) and visualization of the GFP puncta in cross-sections (F). In basal conditions, the number of GFP-positive puncta is significantly higher in RAmKO than in control mice but fails to further increase upon starvation (St24). A volume unit (Vol) displayed in (E) corresponds to 3.6 3 10 5 mm
3
. Data are mean ± SEM; *p < 0.05 compared to control mice in same conditions; $ p < 0.05 compared to same genotype in basal conditions. Scale bar = 50 mm (F). (G) Expression of autophagy-related genes in TA from starved RAmKO mice is reduced compared to starved control mice but upregulated compared to basal conditions. Expressions are normalized to b-actin levels. Values are mean ± SEM; *p < 0.05 compared to control mice under the same condition; $ p < 0.05, $$ p < 0.005 compared to same genotype in basal conditions.
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mTORC1 Inhibits Autophagy Induction in Muscle mTORC2-dependent regulation of Akt (Guertin et al., 2006) , as Akt tends to be more activated and autophagy-related genes were unchanged. These results may foster the development of therapies modulating mTORC1 as a strategy for the treatment of sarcopenia and for muscle pathologies linked to impaired autophagy. Given our findings, therapeutic inhibition of mTORC1 (A) Rapamycin (+) normalizes levels of phosphorylation (P) of Akt and S6 and reduces the accumulation of phospho (P)-Ulk1 S757 and p62 in TA from 2-month-old starved (St24) and from 12-month-old (M, month) TSCmKO mice. The treatment also promotes the conversion of LC3I to LC3II in starved TSCmKO mice. Data are normalized to a-actinin and are representative of three independent experiments; for quantification, see Table S2 .
(B and C) Rapamycin is sufficient to increase the number of GFP-positive puncta in TA muscle from 2-month-old starved TSCmKO mice expressing GFP-LC3 (B). Scale bar = 50 mm. GFP-LC3 puncta were quantified in a volume unit (Vol) of 3.6 3 10 5 mm 3 (C). Values are mean ± SEM. *p < 0.05; **p < 0.005. will only make sense in pathological conditions where autophagy is prevented by hyperactivation of mTORC1. Accordingly, rapamycin treatment of collagen VI-deficient mice, characterized by increased Akt activation, was sufficient to restore autophagy and partly ameliorated the phenotype of the animals (Grumati et al., 2010) . Other muscle pathologies with impaired autophagy related to Akt/mTORC1 misregulation may constitute potential targets for the therapeutic modulation of the mTORC1 pathway, though this will require great care given the complexity of the integrated signaling network.
EXPERIMENTAL PROCEDURES Animal Experiments
Generation and genotyping of RAmKO, RImKO, and GFP-LC3 transgenic mice were described previously (Mizushima et al., 2004; Bentzinger et al., 2008) . TSCmKO mice were obtained by crossing Tsc1-floxed mice (Kwiatkowski et al., 2002) from Jackson Laboratory with transgenic mice expressing Cre recombinase under the control of the human skeletal actin promoter (Schwander et al., 2003) . For starvation experiments, mice were euthanized in the following conditions: ad libitum; at 10 pm (fed) or 10 am (basal); or after 12, 24, 36, or 48 hr with food deprivation (starved) but free access to water. In some experiments, mice were intraperitoneally injected with chloroquine (50 mg/kg; Sigma-Aldrich) or rapamycin (1.5 mg/kg; LC Laboratories) as described previously (Bodine et al., 2001; Grumati et al., 2010) . In vitro force measurements of soleus and EDL muscles were conducted as described previously (Bentzinger et al., 2008) . All procedures were performed in accordance with the Swiss regulations for animal experimentation and approved by the veterinary commission of the Canton Basel-Stadt.
In Vivo Muscle Electroporation
The constructs have been described previously (Kong et al., 2004; Bentzinger et al., 2013) or are detailed in the Supplemental Experimental Procedures. Plasmid for wild-type Ulk1 (Yan et al., 1998) was obtained from Addgene; mutagenesis (S757A) was conducted with QuikChange II XL Site-Directed Mutagenesis Kit (Agilent). Electroporation into muscle fibers was performed as described before (Kong et al., 2004) .
Isolated Single Fibers
Single muscle fibers were isolated from EDL and TA muscles as described previously (Rosenblatt et al., 1995) and incubated for 4 hr in growth medium or PBS before protein extraction or methanol fixation.
Transcript Expression Analyses
Gene expression was quantified by quantitative PCR. Results were normalized to b-actin or a-actinin expression and relative to expression in control mice. Primers are listed in Table S6 .
Western Blotting
Proteins were extracted from TA and soleus muscles as described previously (Bentzinger et al., 2008) . The detergent-insoluble protein fraction was solubilized in lysis buffer supplemented with 2% SDS. Antibodies used for immunoblotting are listed in the Supplemental Experimental Procedures.
Histology and Electron Microscopy
Inorganic colorations, immunostaining, and GFP-LC3 detection were conducted on muscle cryosections as described previously (Mizushima et al., 2004; Bentzinger et al., 2008) . Antibodies are listed in the Supplemental Experimental Procedures. Transmission electron microscopy was performed as described (Moll et al., 2001 ).
Images and Statistical Analyses
Images were analyzed with the analySIS (Soft Imaging System) and Imaris software. Results are expressed as mean ± SEM of independent animals, with n (number of individual experiments) R 3. 
